Exact Mass: 915.4378

Exact Mass Matches: 915.4378

Found 18 metabolites which its exact mass value is equals to given mass value 915.4378, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

anabaenopeptin 915

anabaenopeptin 915

C48H65N7O11 (915.4742)


   
   
   

Liposidomycin X-(III)

Liposidomycin X-(III)

C41H65N5O18 (915.4324)


   

Cargutocin

Cargutocin

C42H65N11O12 (915.4814)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone

   
   

muraymycin D2 zwitterion

muraymycin D2 zwitterion

C37H61N11O16 (915.4298)


   

Hex3Cer 27:6;2O

Hex3Cer 27:6;2O

C45H73NO18 (915.4827)


   

Angiotensin I/II (1-6) (TFA)

Angiotensin I/II (1-6) (TFA)

C38H56F3N11O12 (915.4062)


Angiotensin I/II (1-6) TFA contains the amino acids 1-6 and is converted from Angiotensin I/II peptide. The precursor angiotensinogen is cleaved by renin to form angiotensin I. Angiotensin I ishydrolyzed by angiotensin-converting enzyme (ACE) to form the biologically active angiotensin II. Angiotensin II has been investigated for the treatment, basic science, and diagnostic of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy[1][2][3].

   

Angiotensin I/II (1-6) (TFA)

Angiotensin I/II (1-6) (TFA)

C38H56F3N11O12 (915.4062)


Angiotensin I/II (1-6) TFA contains the amino acids 1-6 and is converted from Angiotensin I/II peptide. The precursor angiotensinogen is cleaved by renin to form angiotensin I. Angiotensin I ishydrolyzed by angiotensin-converting enzyme (ACE) to form the biologically active angiotensin II. Angiotensin II has been investigated for the treatment, basic science, and diagnostic of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy[1][2][3].

   

(2s)-2-{n-[(s)-{[(1s)-1-[(3-{[(1s,2s)-2-{[(2s,3r,4s,5r)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-1-carboxy-2-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]ethyl]amino}propyl)-c-hydroxycarbonimidoyl]-3-methylbutyl]-c-hydroxycarbonimidoyl}[(4s)-2-imino-1,3-diazinan-4-yl]methyl]-(c-hydroxycarbonimidoyl)amino}-3-methylbutanoic acid

(2s)-2-{n-[(s)-{[(1s)-1-[(3-{[(1s,2s)-2-{[(2s,3r,4s,5r)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-1-carboxy-2-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]ethyl]amino}propyl)-c-hydroxycarbonimidoyl]-3-methylbutyl]-c-hydroxycarbonimidoyl}[(4s)-2-imino-1,3-diazinan-4-yl]methyl]-(c-hydroxycarbonimidoyl)amino}-3-methylbutanoic acid

C37H61N11O16 (915.4298)


   

2-[({3-[(acetyloxy)methyl]-2,5,11,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-7-methyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]-3-phenylpropanoic acid

2-[({3-[(acetyloxy)methyl]-2,5,11,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-7-methyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]-3-phenylpropanoic acid

C47H61N7O12 (915.4378)


   

(2s)-2-{n-[(s)-{[(1s,2s)-1-[(3-{[(1s,2s)-2-{[(2s,4s,5r)-5-(aminomethyl)-4-hydroxyoxolan-2-yl]oxy}-1-carboxy-2-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]ethyl]amino}propyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-c-hydroxycarbonimidoyl}[(4s)-2-imino-1,3-diazinan-4-yl]methyl]-(c-hydroxycarbonimidoyl)amino}-3-methylbutanoic acid

(2s)-2-{n-[(s)-{[(1s,2s)-1-[(3-{[(1s,2s)-2-{[(2s,4s,5r)-5-(aminomethyl)-4-hydroxyoxolan-2-yl]oxy}-1-carboxy-2-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]ethyl]amino}propyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-c-hydroxycarbonimidoyl}[(4s)-2-imino-1,3-diazinan-4-yl]methyl]-(c-hydroxycarbonimidoyl)amino}-3-methylbutanoic acid

C37H61N11O16 (915.4298)


   

(2s)-2-({[(3s,6s,9s,12s,15r)-3-[(2s)-butan-2-yl]-2,5,11,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-7-methyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-({[(3s,6s,9s,12s,15r)-3-[(2s)-butan-2-yl]-2,5,11,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-7-methyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid

C48H65N7O11 (915.4742)


   

2-({[5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy}[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl)-6-({3-[(4-carboxy-3-methylbutanoyl)oxy]tridecanoyl}oxy)-1,4-dimethyl-3-oxo-1,4-diazepane-5-carboxylic acid

2-({[5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy}[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl)-6-({3-[(4-carboxy-3-methylbutanoyl)oxy]tridecanoyl}oxy)-1,4-dimethyl-3-oxo-1,4-diazepane-5-carboxylic acid

C41H65N5O18 (915.4324)


   

(2s)-2-({[(3s,6s,9s,12s,15r)-3-[(2s)-butan-2-yl]-2,5,8,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-10-methyl-11-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,7,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-({[(3s,6s,9s,12s,15r)-3-[(2s)-butan-2-yl]-2,5,8,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-10-methyl-11-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,7,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid

C48H65N7O11 (915.4742)


   

3-(4-hydroxyphenyl)-2-[({2,5,11,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-7-methyl-8-oxo-3-(sec-butyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]propanoic acid

3-(4-hydroxyphenyl)-2-[({2,5,11,14-tetrahydroxy-6,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-7-methyl-8-oxo-3-(sec-butyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]propanoic acid

C48H65N7O11 (915.4742)


   

3-methyl-2-[({2,5,11,14-tetrahydroxy-6-[2-(4-hydroxyphenyl)ethyl]-12-(2-methanesulfinylethyl)-7-methyl-3-[2-(methylsulfanyl)ethyl]-8-oxo-9-(2-phenylethyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]pentanoic acid

3-methyl-2-[({2,5,11,14-tetrahydroxy-6-[2-(4-hydroxyphenyl)ethyl]-12-(2-methanesulfinylethyl)-7-methyl-3-[2-(methylsulfanyl)ethyl]-8-oxo-9-(2-phenylethyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]pentanoic acid

C44H65N7O10S2 (915.4234)